| Illustrative case and discussion: a 58-year-old man with diabetes. | |
| | |
MedLine Citation:
|
PMID: 20644203 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
The following illustrative case presentation was introduced by Jeffrey S. Freeman, DO, at the symposium titled "Incretin-Based Therapies: Bridging the Gap Between Clinical Experiences and Emerging Applications in Type 2 Diabetes." The program was conducted Thursday, November 5, 2009, at the American Osteopathic Association's 114th Annual Osteopathic Medical Conference and Exposition in New Orleans, Louisiana. Discussion excerpts from the symposium participants regarding treatment options for the patient are included. |
| | |
Authors:
|
Jeffrey S Freeman |
Related Documents
:
|
16476123 - Trends in the use of oral antidiabetic drugs by outpatients in taiwan: 1997-2003. 15222663 - The utility of insulin glargine in the treatment of diabetes mellitus. 2627763 - Erythrocyte glyoxalase activity in genetically obese (ob/ob) and streptozotocin diabeti... |
Publication Detail:
|
Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The Journal of the American Osteopathic Association Volume: 110 ISSN: 1945-1997 ISO Abbreviation: J Am Osteopath Assoc Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-07-20 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7503065 Medline TA: J Am Osteopath Assoc Country: United States |
Other Details:
|
Languages: eng Pagination: eS25-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Incretin physiology and its role in type 2 diabetes mellitus.
Next Document: Risks and benefits of attaining HbA(1c) goals: examining the evidence.